Pengaruh SSRIs Untuk Meningkatkan Independensi Fungsional Pada Pasien Depresi Pasca Stroke

Effect of SSRIs to Improve Functional Independence in Post-Stroke Depression Patients

Authors

  • Winda Puspita Salim Program Studi Kedokteran Fakultas Kedokteran Universitas Mulawarman Author
  • Yetty Octavia Hutahaean Laboratorium Neurologi Fakultas Kedokteran Universitas Mulawarman/ RSUD AW. Sjahranie Author
  • Fransiska Anggreni Sihotang Laboratorium Fisiologi Fakultas Kedokteran Universitas Mulawarman Author

Keywords:

SSRI, Depresi Pasca-stroke, Independensi Fungsional

Abstract

Depresi Pasca-Stroke menyebabkan dampak negatif terhadap independensi fungsional pasien dalam melakukan aktivitas sehari-hari. Selective serotonin reuptake inhibitors (SSRIs) merupakan golongan antidepresan yang direkomendasikan sebagai lini pertama terapiuntuk mengobati Depresi Pasca-Stroke karena profil tolerabilitasnya yang menguntungkan. Tinjauan pustaka ini ditujukan untuk menyajikan suatu wawasan pengetahuan yang baru tentang pengaruh SSRIs meningkatkan independensi fungsional pada pasien depresi pasca-stroke. Peneliti menerapkan desain penelitian kualitatif. Referensi yang digunakan diakses dari dua database yaitu PubMed dan Google Scholar dan hanya mengambil jurnal berbahasa Inggris. Peneliti membatasi tahun terbit jurnal mulai 2010 hingga 2020. Dari hasil pencarian, peneliti menemukan sekitar 52.984 jurnal, tetapi peneliti hanya menggunakan 5 jurnal sesuai dengan kriteria inklusi yaitu jurnal Randomized Controlled Trial (RCT) yang menguji manfaat pengobatan SSRIs pada pasien Depresi Pasca-Stroke yang dibandingkan dengan antidepresan lain atau modalitas pengobatan lainnya, serta terdapat pengukuran outcomeindependensi fungsional. Berdasarkan tinjauan pustaka dapat disimpulkan bahwa, SSRI berpengaruh terhadap perbaikan independensi fungsional pada pasien Depresi Pasca-Stroke. SSRI pun terbukti memiliki efek yang positif dangan beragam kombinasi modalitas terapi non-farmakologis sebagai penunjangnya.

References

Towfighi A, Ovbiagele B, El Husseini N, Hackett ML, Jorge RE, Kissela BM, et al. Poststroke Depression: A Scientific Statement for Healthcare Professionals from the American Heart Association/American Stroke Association. Stroke. 2017;48(2):e30–43.

Castilla-Guerra L, Fernandez Moreno M del C, Esparrago-Llorca G, Colmenero-Camacho MA. Pharmacological management of post-stroke depression. Expert Rev Neurother [Internet]. 2020;20(2):157–66. Available from: https://doi.org/10.1080/14737175.2020.1707666

Espárrago Llorca G, Castilla-Guerra L, Fernández Moreno MC, Ruiz Doblado S, Jiménez Hernández MD. Depresión post ictus: Una actualización. Neurologia [Internet]. 2015;30(1):23–31. Available from: http://dx.doi.org/10.1016/j.nrl.2012.06.008

Berg A, Palomäki H, Lehtihalmes M, Lönnqvist J, Kaste M. Poststroke depression in acute phase after stroke. Cerebrovasc Dis. 2001;12(1):14–20.

Vika WN, Syarifah AS, Ratnawati M. Hubungan Status Fungsional Dengan Tingkat Depresi Pada Pasien Stroke Di Ruang Flamboyan Rsud Jombang. J Ilm Kebidanan (Scientific J Midwifery). 2018;4(1):52–9.

Khomsiatun. Hubungan status fungsional terhadap depresi pada pasien stroke di ruang fisioterapi di rsud wilayah kabupaten semarang. 2015;

Feng C, Fang M, Liu XY. The neurobiological pathogenesis of poststroke depression. Sci World J. 2014;2014.

Guajardo VD, Terroni L, Sobreiro MDFM, Zerbini MIDS, Tinone G, Scaff M, et al. The influence of depressive symptoms on quality of life after stroke: A prospective study. J Stroke Cerebrovasc Dis. 2015;24(1):201–9.

Cai W, Mueller C, Li YJ, Shen WD, Stewart R. Post stroke depression and risk of stroke recurrence and mortality: A systematic review and meta-analysis. Ageing Res Rev [Internet]. 2019;50:102–9. Available from: https://doi.org/10.1016/j.arr.2019.01.013

Dar et al. Post Stroke Depression Frequently Overlooked, Undiagnosed, Untreated. Neuropsychiatry (London). 2017;07(06):906–19.

Stokes&Hasan. Depression after stroke: A review of the evidence base to inform the development of an integrated care pathway. Part 2: Treatment alternatives. Clin Rehabil. 2002;16(3):248–60.

Gruenbaum BF, Kutz R, Zlotnik A. Blood glutamate scavenging sebagai pendekatan terapi berbasis glutamat baru untuk depresi pasca-stroke. 2020;0:1–14.

Chollet F, Tardy J, Albucher JF, Thalamas C, Berard E, Lamy C, et al. Fluoxetine for motor recovery after acute ischaemic stroke (FLAME): A randomised placebo-controlled trial. Lancet Neurol [Internet]. 2011;10(2):123–30. Available from: http://dx.doi.org/10.1016/S1474-4422(10)70314-8

Savadi Oskouie D, Sharifipour E, Sadeghi Bazargani H, Hashemilar M, Nikanfar M, Ghazanfari Amlashi S, et al. Efficacy of Citalopram on Acute Ischemic Stroke Outcome: A Randomized Clinical Trial. Neurorehabil Neural Repair. 2017;31(7):638–47.

Gu SC, Wang C De. Early Selective Serotonin Reuptake Inhibitors for Recovery after Stroke: A Meta-Analysis and Trial Sequential Analysis. J Stroke Cerebrovasc Dis [Internet]. 2018;27(5):1178–89. Available from: https://doi.org/10.1016/j.jstrokecerebrovasdis.2017.11.031

Kraglund KL, Mortensen JK, Grove EL, Johnsen SP, Andersen G. TALOS: A multicenter, randomized, double-blind, placebo-controlled trial to test the effects of citalopram in patients with acute stroke. Int J Stroke. 2015;10(6):985–7.

Hong W, Zhao Z, Wang D, Li M, Tang C, Li Z, et al. Altered gray matter volumes in post-stroke depressive patients after subcortical stroke. NeuroImage Clin [Internet]. 2020;26(September 2019):102224. Available from: https://doi.org/10.1016/j.nicl.2020.102224

Chemerinski et al. Improved recovery in activities of daily living associated with remission of poststroke depression. Stroke. 2001;32(1):113–7.

Zhou S, Liu S, Liu X, Zhuang W. Selective serotonin reuptake inhibitors for functional independence and depression prevention in early stage of post-stroke: A meta-analysis. Med (United States). 2020;99(6):1–8.

Kwon CY, Lee B, Chung SY, Kim JW, Shin A, Choi Y yong, et al. Efficacy and safety of Sihogayonggolmoryeo-tang (Saikokaryukotsuboreito, Chai-Hu-Jia-Long-Gu-Mu-Li-Tang) for post-stroke depression: A systematic review and meta-analysis. Sci Rep. 2019;9(1):1–20.

Mikami K, Jorge RE, Adams HP, Davis PH, Leira EC, Jang M, et al. Effect of antidepressants on the course of disability following stroke. Am J Geriatr Psychiatry [Internet]. 2011;19(12):1007–15. Available from: http://dx.doi.org/10.1097/JGP.0b013e31821181b0

Schmidt HD, Duman RS. The role of neurotrophic factors in adult hippocampal neurogenesis, antidepressant treatments and animal models of depressive-like behavior. Behav Pharmacol. 2007;18(5–6):391–418.

Imran et al. Efektifitas New Bobath Concept Terhadap Peningkatan Fungsional Pasien Stroke Iskemik dengan Outcome Stroke Diukur Menggunakan Fungsional Independent Measurement ( Fim ) dan Glasgow Outcome Scale ( GOS ) Di RSUDZA 2018. J Med Sci. 2020;1(1):14–20.

Kim et al. Efficacy of early administration of escitalopram on depressive and emotional symptoms and neurological dysfunction after stroke: a multicentre, double-blind, randomised, placebo-controlled study. The Lancet Psychiatry [Internet]. 2017;4(1):33–41. Available from: http://dx.doi.org/10.1016/S2215-0366(16)30417-5

Robinson et al. Clinical Neuropsychiatry of Stroke. 2006;

Gao J, Lin M, Zhao J, Bi S, Ni Z, Shang X. Different interventions for post-ischaemic stroke depression in different time periods: A single-blind randomized controlled trial with stratification by time after stroke. Clin Rehabil. 2017;31(1):71–81.

Lanctôt KL, Lindsay MP, Smith EE, Sahlas DJ, Foley N, Gubitz G, et al. Canadian Stroke Best Practice Recommendations: Mood, Cognition and Fatigue following Stroke, 6th edition update 2019. Int J Stroke. 2019;0(0):1–21.

Man S, Hung BHB, Ng RMK, Yu X, Cheung H, Fung MPM, et al. A pilot controlled trial of a combination of dense cranial electroacupuncture stimulation and body acupuncture for post-stroke depression. 2014;1–8.

Razazian N, Esmaeili O, Almasi A. Effect of Fluoxetine on Motor Improvement in Ischemic Stroke Patients: A Double Blind Clinical Trial Study. Zahedan J Res Med Sci. 2016;18(7).

Miyai I, Reding MJ. Effects of Antidepressants on Functional Recovery Following Stroke: A Double-Blind Study. Neurorehabil Neural Repair. 1998;12(1):5–13.

Gonzalez-Torrecillas JL, Mendlewicz J, Lobo A. Effects of Early Treatment of Poststroke Depression on Neuropsychological Rehabilitation. Int Psychogeriatrics. 1995;7(4):547–60.

Gainotti G, Antonucci G, Marra C, Paolucci S. Relation between depression after stroke, antidepressant therapy, and functional recovery. J Neurol Neurosurg Psychiatry. 2001;71(2):258–61.

Loubinoux I, Pariente J, Boulanouar K, Carel C, Manelfe C, Rascol O, et al. A single dose of the serotonin neurotransmission agonist paroxetine enhances motor output: Double-blind, placebo-controlled, fMRI study in healthy subjects. Neuroimage. 2002;15(1):26–36.

Pariente J, Loubinoux I, Carel C, Albucher JF, Leger A, Manelfe C, et al. Fluoxetine modulates motor performance and cerebral activation of patients recovering from stroke. Ann Neurol. 2001;50(6):718–29.

Stamenkovic et al. Poststroke Depression and Fluoxetine. 1996;(March):446–7.

Zhaosheng D, Fang Z, Maming LIN, Yun W. Effect of Fluoxetine on Expression of Brain- derived Neurotrophic Factor in Patients with Post-stroke Depression. 2014;2(4):467–71.

Downloads

Published

2024-11-14

Issue

Vol. 3 No. 3 (2021): J. Sains Kes.

Section

Review

How to Cite

Pengaruh SSRIs Untuk Meningkatkan Independensi Fungsional Pada Pasien Depresi Pasca Stroke: Effect of SSRIs to Improve Functional Independence in Post-Stroke Depression Patients. (2024). Jurnal Sains Dan Kesehatan, 3(3), 529-537. https://jsk.ff.unmul.ac.id/index.php/JSK/article/view/288